| Grene Vision Group Llc | |
|
707 W Main St, Anthony, KS 67003-2752 | |
| (620) 842-5596 | |
| (620) 842-3521 |
| Full Name | Grene Vision Group Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 707 W Main St, Anthony, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588876262 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| 207W00000X | Ophthalmology | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Grene Vision Group Llc 1851 N Webb Rd, Attn Flr2, Wichita, KS 67206-3413 Ph: (316) 636-2010 | Grene Vision Group Llc 707 W Main St, Anthony, KS 67003-2752 Ph: (620) 842-5596 |
News Archive
During this turbulent year for the financial services industry, insurance businesses have not been immune to public scrutiny and fiscal pressures. The news of struggling holding companies leaked into the business side of insurance, creating skepticism and frustration for many policyholders who are worried about being able to plan and protect themselves and their families.
In a major breakthrough that comes after decades of research and nearly half a billion treatments in humans, scientists have finally unlocked how a key anti-parasitic drug kills the worms brought on by the filarial diseases river blindness and elephantitis.
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a new technique that uses modified insulin and red blood cells to create a glucose-responsive "smart" insulin delivery system.
Late-breaking data from the SPIRIT IV trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System achieved superiority in the key safety and efficacy measures of target lesion failure (TLF) and target lesion revascularization (TLR) compared to the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year.
› Verified 2 days ago
Daniel Marchant, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 707 W Main St, Anthony, KS 67003 Phone: 620-842-5596 Fax: 620-842-3521 | |
Steven A. Kuhl O.d., Llc Optometrist Medicare: Medicare Enrolled Practice Location: 115 W Main, Anthony, KS 67003 Phone: 620-842-5596 Fax: 620-842-3521 |